Australian Rotavirus Surveillance Program annual report, 2008/2009

Authors

  • Carl D Kirkwood Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • Karen Boniface Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • Ruth F Bishop Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • Graeme L Barnes Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria
  • Australian Rotavirus Surveillance Group National Rotavirus Reference Centre, Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Victoria

DOI:

https://doi.org/10.33321/cdi.2009.33.41

Keywords:

Rotavirus, disease surveillance

Abstract

The Australian Rotavirus Surveillance Program together with collaborating laboratories Australia-wide, conducts a laboratory based rotavirus surveillance program. This report describes the genotypes of rotavirus strains responsible for the hospitalisation of children with acute gastroenteritis during the period 1 July 2008 to 30 June 2009, the second year of surveillance following introduction of rotavirus vaccine into the National Immunisation Program. Five hundred and ninety-two faecal samples from across Australia were examined for G and P genotype using hemi-nested multiplex reverse transcription-polymerase chain reaction assays. Of the 445 confirmed as rotavirus positive, genotype G2P[4] was the dominant type nationally, representing 50.3%, followed by genotype G1P[8] (22.5%). Genotypes G3P[8], G4P[8] and G9P[8] each represented less than 5% of circulating strains nationally. Uncommon rotavirus genotype combinations, including G1P[4] (n = 6), G4P[4] (n = 2) and single strains of G1P[6] and G3P[6] were identified during this study period. The national dominance of G2P[4] was associated with a large outbreak of severe gastroenteritis in Alice Springs in early 2009. This is the first report to describe G2P[4] as the dominant genotype nationally. Whether vaccine pressure has resulted in emergence of this genotype is not yet known. Commun Dis Intell 2009;33:382–388.

Downloads

Download data is not yet available.

References

Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12(2):304–306.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354(1):23–33.

Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354(1):11–22.

Carlin JB, Chondros P, Masendycz P, Bugg H, Bishop RF, Barnes GL. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993–1996. Med J Aust 1998;169:252–256.

Galati JC, Harsley S, Richmond P, Carlin JB. The burden of rotavirus-related illness among young children on the Australian health care system. Aust N Z J Public Health 2006;30(5):416–421.

Kirkwood CD, Cannan D, Bogdanovic-Sakran N, Bishop RF, Barnes GL, National Rotavirus Surveillance Group. National Rotavirus Surveillance Program annual report, 2005–06. Commun Dis Intell 2006;30(4):434–438.

Kirkwood CD, Cannan D, Bogdanovic-Sakran N, Bishop R, Barnes G. Australian Rotavirus Surveillance Program, annual report, 2006–07. Commun Dis Intell 2007;31(4):375–379

Kirkwood CD, Cannan D, Boniface K, Bishop R, Barnes G. Australian Rotavirus Surveillance Program annual report, 2007/08. Commun Dis Intell .2008;32(4):425–429.

Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, Fang ZY. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28(2):276–282.

Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992;30(6):1365–1373.

Werther RL, Crawford NW, Boniface K, Kirkwood CD, Smart JM. Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency. J Allergy Clin Immunol 2009;124(3):600.

Kirkwood C, Bogdanovic-Sakran N,Bishop R, Barnes G. Report of Australian Rotavirus Surveillance Program, 2003/2004. Commun Dis Intell 2004;28(4):481–485.

Gurgel RQ, Cuevas LE, Vieira SC, Barros VC, Fontes PB, Salustino EF, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2007;13(10):1571–1573.

Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol 2008;153(3):591–593.

Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009;301(21):2243–2251.

Patel MM, de Oliveira LH, Bispo AM, Gentsch J, Parashar UD. Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2008;14(5):863–865.

Gentsch JR, Laird AR, Biefelt B, Griffin DD, Banyau K, Ramachandran M, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005;192 (Suppl 1):S146–S159.

Downloads

Published

01/12/09

How to Cite

Kirkwood, Carl D, Karen Boniface, Ruth F Bishop, Graeme L Barnes, and Australian Rotavirus Surveillance Group. 2009. “Australian Rotavirus Surveillance Program Annual Report, 2008 2009”. Communicable Diseases Intelligence 33 (December):382-88. https://doi.org/10.33321/cdi.2009.33.41.